vs
OXFORD INDUSTRIES INC（OXM）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
OXFORD INDUSTRIES INC的季度营收约是Ultragenyx Pharmaceutical Inc.的1.5倍（$307.3M vs $207.3M），OXFORD INDUSTRIES INC净利率更高（-20.7% vs -62.0%，领先41.3%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs -0.2%），OXFORD INDUSTRIES INC自由现金流更多（$-47.9M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs -3.0%）
牛津工业公司是美国一家上市服装企业，主打高端服装及服饰产品，旗下拥有多个知名品牌，包括汤米·巴哈马、莉莉·普利策、强尼·瓦斯和萨瑟恩泰德等。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
OXM vs RARE — 直观对比
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $307.3M | $207.3M |
| 净利润 | $-63.7M | $-128.6M |
| 毛利率 | 60.3% | — |
| 营业利润率 | -27.7% | -54.7% |
| 净利率 | -20.7% | -62.0% |
| 营收同比 | -0.2% | 25.9% |
| 净利润同比 | -1517.6% | 3.5% |
| 每股收益（稀释后） | $-4.28 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $307.3M | $207.3M | ||
| Q3 25 | $403.1M | $159.9M | ||
| Q2 25 | $392.9M | $166.5M | ||
| Q1 25 | — | $139.3M | ||
| Q4 24 | $308.0M | $164.6M | ||
| Q3 24 | $419.9M | $139.5M | ||
| Q2 24 | $398.2M | $147.0M | ||
| Q1 24 | $404.4M | $108.8M |
| Q4 25 | $-63.7M | $-128.6M | ||
| Q3 25 | $16.7M | $-180.4M | ||
| Q2 25 | $26.2M | $-115.0M | ||
| Q1 25 | — | $-151.1M | ||
| Q4 24 | $-3.9M | $-133.2M | ||
| Q3 24 | $40.6M | $-133.5M | ||
| Q2 24 | $38.4M | $-131.6M | ||
| Q1 24 | $-60.1M | $-170.7M |
| Q4 25 | 60.3% | — | ||
| Q3 25 | 61.4% | — | ||
| Q2 25 | 64.2% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 63.1% | — | ||
| Q3 24 | 63.1% | — | ||
| Q2 24 | 64.9% | — | ||
| Q1 24 | 60.9% | — |
| Q4 25 | -27.7% | -54.7% | ||
| Q3 25 | 6.3% | -106.9% | ||
| Q2 25 | 9.2% | -64.8% | ||
| Q1 25 | — | -102.6% | ||
| Q4 24 | -2.0% | -74.3% | ||
| Q3 24 | 12.5% | -94.6% | ||
| Q2 24 | 13.2% | -79.1% | ||
| Q1 24 | -20.1% | -151.9% |
| Q4 25 | -20.7% | -62.0% | ||
| Q3 25 | 4.1% | -112.8% | ||
| Q2 25 | 6.7% | -69.0% | ||
| Q1 25 | — | -108.5% | ||
| Q4 24 | -1.3% | -80.9% | ||
| Q3 24 | 9.7% | -95.7% | ||
| Q2 24 | 9.6% | -89.5% | ||
| Q1 24 | -14.9% | -156.8% |
| Q4 25 | $-4.28 | $-1.28 | ||
| Q3 25 | $1.12 | $-1.81 | ||
| Q2 25 | $1.70 | $-1.17 | ||
| Q1 25 | — | $-1.57 | ||
| Q4 24 | $-0.25 | $-1.34 | ||
| Q3 24 | $2.57 | $-1.40 | ||
| Q2 24 | $2.42 | $-1.52 | ||
| Q1 24 | $-3.72 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $8.0M | $421.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $528.0M | $-80.0M |
| 总资产 | $1.3B | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $8.0M | $421.0M | ||
| Q3 25 | $6.9M | $202.5M | ||
| Q2 25 | $8.2M | $176.3M | ||
| Q1 25 | — | $127.1M | ||
| Q4 24 | $7.0M | $174.0M | ||
| Q3 24 | $18.4M | $150.6M | ||
| Q2 24 | $7.7M | $480.7M | ||
| Q1 24 | $7.6M | $112.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $29.0M | — |
| Q4 25 | $528.0M | $-80.0M | ||
| Q3 25 | $597.1M | $9.2M | ||
| Q2 25 | $592.4M | $151.3M | ||
| Q1 25 | — | $144.2M | ||
| Q4 24 | $612.2M | $255.0M | ||
| Q3 24 | $621.6M | $346.8M | ||
| Q2 24 | $592.9M | $432.4M | ||
| Q1 24 | $560.9M | $140.3M |
| Q4 25 | $1.3B | $1.5B | ||
| Q3 25 | $1.3B | $1.2B | ||
| Q2 25 | $1.3B | $1.3B | ||
| Q1 25 | — | $1.3B | ||
| Q4 24 | $1.2B | $1.5B | ||
| Q3 24 | $1.2B | $1.5B | ||
| Q2 24 | $1.2B | $1.6B | ||
| Q1 24 | $1.1B | $1.3B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.05× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-9.1M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $-47.9M | $-100.8M |
| 自由现金流率自由现金流/营收 | -15.6% | -48.6% |
| 资本支出强度资本支出/营收 | 12.6% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-79.9M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $-9.1M | $-99.8M | ||
| Q3 25 | $83.5M | $-91.4M | ||
| Q2 25 | $-3.9M | $-108.3M | ||
| Q1 25 | — | $-166.5M | ||
| Q4 24 | $-18.2M | $-79.3M | ||
| Q3 24 | $88.8M | $-67.0M | ||
| Q2 24 | $32.9M | $-77.0M | ||
| Q1 24 | $74.9M | $-190.7M |
| Q4 25 | $-47.9M | $-100.8M | ||
| Q3 25 | $52.3M | $-92.7M | ||
| Q2 25 | $-27.4M | $-110.7M | ||
| Q1 25 | — | $-167.8M | ||
| Q4 24 | $-56.9M | $-79.5M | ||
| Q3 24 | $47.2M | $-68.6M | ||
| Q2 24 | $21.0M | $-79.0M | ||
| Q1 24 | $55.3M | $-193.9M |
| Q4 25 | -15.6% | -48.6% | ||
| Q3 25 | 13.0% | -58.0% | ||
| Q2 25 | -7.0% | -66.5% | ||
| Q1 25 | — | -120.5% | ||
| Q4 24 | -18.5% | -48.3% | ||
| Q3 24 | 11.2% | -49.2% | ||
| Q2 24 | 5.3% | -53.7% | ||
| Q1 24 | 13.7% | -178.2% |
| Q4 25 | 12.6% | 0.5% | ||
| Q3 25 | 7.7% | 0.8% | ||
| Q2 25 | 6.0% | 1.5% | ||
| Q1 25 | — | 1.0% | ||
| Q4 24 | 12.6% | 0.1% | ||
| Q3 24 | 9.9% | 1.2% | ||
| Q2 24 | 3.0% | 1.4% | ||
| Q1 24 | 4.8% | 3.0% |
| Q4 25 | — | — | ||
| Q3 25 | 5.00× | — | ||
| Q2 25 | -0.15× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.19× | — | ||
| Q2 24 | 0.86× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OXM
| Sales Channel Retail | $162.9M | 53% |
| Sales Channel Wholesale | $61.3M | 20% |
| Johnny Was | $45.4M | 15% |
| Sales Channel Food And Beverage | $29.3M | 10% |
| Other Foreign Countries | $9.0M | 3% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
